Nymox Pharmaceutical Corp Beta
Mi az Nymox Pharmaceutical Corp Beta?
A Beta az Nymox Pharmaceutical Corp - 0.00
Mi a Beta meghatározása?
A BETA azt jelzi, hogy az állomány több-kevésbé volatilis, mint a piac egésze. Az 1-nél kevesebb béta azt jelzi, hogy az állomány kevésbé ingadozó, mint a piac, míg az 1-nél nagyobb béta azt jelzi, hogy az állomány volatilisabb. A volatilitást az átlag körüli ár ingadozásaként méri.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta a Health Care szektor a NASDAQ-on cégekben a Nymox Pharmaceutical Corp -hoz képest
Mit csinál Nymox Pharmaceutical Corp?
nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.
beta -hoz hasonló cégek Nymox Pharmaceutical Corp
- Vision Marine Technologies nak Beta 0.00 van
- Ely Gold Royalties nak Beta 0.00 van
- Glacier Lake Resources nak Beta 0.00 van
- Magnum Mining and Exploration nak Beta 0.00 van
- Africa Opportunity Fund nak Beta 0.00 van
- Fulcrum Utility Services nak Beta 0.00 van
- Nymox Pharmaceutical Corp nak Beta 0.00 van
- Gullewa nak Beta 0.00 van
- S.A.L. Steel nak Beta 0.00 van
- Andina Acquisition III nak Beta 0.00 van
- Andina Acquisition III nak Beta 0.00 van
- Brilliant Acquisition nak Beta 0.00 van
- Indokem nak Beta 0.00 van